Drug
Garetosmab
Garetosmab: highest development phase Phase 3, developed by Regeneron. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Regeneron
Trials
| Drug | Phase | Indication |
|---|---|---|
| garetosmab NCT07559513 | Phase 3 | Fibrodysplasia Ossificans Progressiva |
Latest
No recent events.
Follow Garetosmab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.